liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Key Elements Contributing to Adverse Drug Interaction Safety Signals in DRUG SAFETY, vol 34, issue 10, pp 1004-1005
WHO Collaborating Centre Int Drug Monitoring.
WHO Collaborating Centre Int Drug Monitoring.
Linköping University, Department of Medical and Health Sciences, Clinical Pharmacology. Linköping University, Faculty of Health Sciences. Östergötlands Läns Landsting, Centre for Diagnostics, Department of Clinical Pharmacology.
2011 (English)In: DRUG SAFETY, Adis , 2011, Vol. 34, no 10, 1004-1005 p.Conference paper, Published paper (Refereed)
Abstract [en]

n/a

Place, publisher, year, edition, pages
Adis , 2011. Vol. 34, no 10, 1004-1005 p.
National Category
Medical and Health Sciences
Identifiers
URN: urn:nbn:se:liu:diva-71767ISI: 000295443500258OAI: oai:DiVA.org:liu-71767DiVA: diva2:453967
Available from: 2011-11-04 Created: 2011-11-04 Last updated: 2011-11-04

Open Access in DiVA

No full text

Authority records BETA

Hägg, Staffan

Search in DiVA

By author/editor
Hägg, Staffan
By organisation
Clinical PharmacologyFaculty of Health SciencesDepartment of Clinical Pharmacology
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 51 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf